Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Arzneiwerk AG VIDA (TLIK.F)

0.5300
+0.0700
+(15.22%)
At close: April 30 at 3:29:02 PM GMT+2
Loading Chart for TLIK.F
  • Previous Close 0.4600
  • Open 0.5250
  • Bid 0.5000 x --
  • Ask 0.6000 x --
  • Day's Range 0.5250 - 0.5300
  • 52 Week Range 0.2860 - 1.0400
  • Volume 400
  • Avg. Volume 7
  • Market Cap (intraday) 3.304M
  • Beta (5Y Monthly) 0.87
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1900
  • Earnings Date May 26, 2025 - May 30, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.

www.arzneiwerk.ag

39

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TLIK.F

View More

Performance Overview: TLIK.F

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

TLIK.F
7.83%
DAX P (^GDAXI)
13.00%

1-Year Return

TLIK.F
46.46%
DAX P (^GDAXI)
25.46%

3-Year Return

TLIK.F
88.12%
DAX P (^GDAXI)
59.58%

5-Year Return

TLIK.F
50.19%
DAX P (^GDAXI)
107.12%

Compare To: TLIK.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TLIK.F

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    3.30M

  • Enterprise Value

    13.84M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.60

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    6.69

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.69%

  • Return on Assets (ttm)

    -7.41%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    59.68M

  • Net Income Avi to Common (ttm)

    -2.15M

  • Diluted EPS (ttm)

    -0.1900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.08M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.64M

Research Analysis: TLIK.F

View More

Company Insights: TLIK.F

Research Reports: TLIK.F

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.